Investing.com - Idorsia reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Idorsia announced earnings per share of CHF-1.22 on revenue of CHF21.03. Analysts polled by Investing.com anticipated EPS of CHF-1.21 on revenue of CHF28.43M.
Idorsia shares are down 26% from the beginning of the year and are trading at CHF13.98 , down-from-52-week-high.
Idorsia follows other major Healthcare sector earnings this month
Idorsia's report follows an earnings matched by Santhera Pharmaceuticals Holding on Thursday, September 29, 2022, who reported EPS of CHF-0.2 on revenue of CHF1.7M, compared to forecasts EPS of CHF-0.2 on revenue of CHF1.7M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar